Self-Amplifying mRNA Seasonal Influenza Vaccine (Arcturus Therapeutics)

自扩增信使RNA季节性流感疫苗 (Arcturus Therapeutics)

Report date: 2024/01/15 14:30:00

Base Information

Drug NameSelf-Amplifying mRNA Seasonal Influenza Vaccine (Arcturus Therapeutics)
Drug Alias NameSelf-Amplifying RNA Seasonal Influenza Vaccine(Arcturus Therapeutics)自扩增RNA季节性流感疫苗 (Arcturus Therapeutics)ARCT-2138
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArcturus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcturus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A